Global Vagal Nerve Stimulation Market – Highlights
Vagal nerve stimulation is a treatment for neurological disorders like epilepsy that involves a stimulator or pulse generator, which is placed inside the body and connected to the left vagal nerve in the neck.
The stimulator sends regular, mild electrical stimulations through this nerve to help calm down the irregular electrical brain activity that leads to seizures.
The global vagal nerve stimulation or Vagal Nerve Stimulation market is expected to grow at a CAGR of ~ 8.68 % during the forecast period 2017-2023.
Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/4479
According to Migraine Research Foundation, (2014), migraine was the 3rd most prevalent illness in the world. Nearly 1 in 4 U.S. households includes someone with migraine.
Moreover, 12% of the population including children have migraine problem. 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.
Global Vagal Nerve Stimulation Market – Key Players
Some of key the players in the market are
- LivaNova PLC (UK)
- EnteroMedics Inc. (US)
- ElectroCore Medical LLC (US)
- Boston Scientific Corporation (US)
- Cyberonics, Inc. (US)
- NeuroMetrix, Inc. (US)
- ImThera Medical (US)
- Inspire Medical Systems, Inc. (US)
Global Vagal Nerve Stimulation Market – Regional Analysis
The Americas dominates the global vagal nerve stimulation market owing to the presence of huge patient population with neurological disorder such as depression, epilepsy, and migraine, high healthcare spending, and increasing government support for research & development.
Europe holds the second largest share of the global vagal nerve stimulation market. The increasing focus of various government agencies on treating epilepsy, depression, and heart attacks will have a positive impact on the growth of the market. The growing public awareness will boost the adoption of these devices in the Europe market.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Global Vagal Nerve Stimulation Market – Segmentation
The global vagal nerve stimulation market is segmented on the basis of products, application, and end user.
- On the basis of products, the market is segmented into implantable VNS devices and external VNS devices.
- On the basis of application, the market is segmented into depression, epilepsy, migraine, and others.
- On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and others.
Major Points form TOC for Vagal Nerve Stimulation Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Vagal Nerve Stimulation Market, By Type
Chapter 7. Global Vagal Nerve Stimulation Market, By Treatment
Chapter 8 Global Vagal Nerve Stimulation Market, By End User
Chapter 9. Global Vagal Nerve Stimulation Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/4479
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com